Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2026

Genmab — Januar 2026

Planlagt Fastgjort Låst Flyttet Genmab
295 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Pensionisten
    wrote on sidst redigeret af
    #221

    Føj......(-:

    1 Reply Last reply
    0
    • W Offline
      W Offline
      w
      wrote on sidst redigeret af
      #222

      genmab classic

      1 Reply Last reply
      0
      • V Offline
        V Offline
        Vitus
        wrote on sidst redigeret af
        #223

        Massakren er en realitet

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #224

          The number of patients in the recent data shows that China is not included so far

          1 Reply Last reply
          0
          • P Offline
            P Offline
            Pensionisten
            wrote on sidst redigeret af
            #225

            Der blev lidt tavst på chatten ! Er det Over and out, and RIP?

            1 Reply Last reply
            0
            • concilladoC Offline
              concilladoC Offline
              concillado
              wrote on sidst redigeret af
              #226

              Man skulle da lige have taget lidt gevinsthjemtagning i 2250 😉

              1 Reply Last reply
              0
              • G Offline
                G Offline
                gdn55
                wrote on sidst redigeret af
                #227

                Hvorfor det

                1 Reply Last reply
                0
                • concilladoC Offline
                  concilladoC Offline
                  concillado
                  wrote on sidst redigeret af
                  #228

                  ...inden Trump-babyen gik i gang igen. "Kun" 3 år tilbage med hans rablende infantile vanvid xD

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #229

                    ok gentogen , than we have something to look forward to

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #230

                      DNB Carnegie løfter Genmabs anbefaling til "køb" og skruer pænt op for kursmålet https://proinvestor.com/investornyt/1405261/dnb-carnegie-lofter-genmabs-anbefaling-til-kob-og-skruer-paent-op-for-kursmalet

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #231

                        hey gentogen , thinking again on that China part of the trial ; too many Asian patients in the trial was where Roche/Genentech got in trouble with Columvi wasn't it; they got a Complete Response Letter from the FDA for the reason that OS was much better in Asian patients compared to non-Asian patients so FDA determined OS was not proven for Americans

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #232

                          and that was Columvi chemo combination and they
                          still have the accelerated approval

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #233
                            • 4Q DARZALEX REVENUE $3.90B, EST. $3.75B
                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #234

                              https://ir.genmab.com/news-releases/news-release-details/genmab-announces-net-sales-darzalexr-daratumumab-2025

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #235

                                Far above top end of prognosis interval.

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  Peter_Panik
                                  wrote on sidst redigeret af
                                  #236

                                  Genmabs amerikanske partner Johnson & Johnson overgår analytikernes forventninger med sine salgstal for kræftmidlet Darzalex i fjerde kvartal.

                                  Salget af Darzalex løber op i 3903 mio. dollar i perioden, mens analytikere havde ventet 3748 mio. dollar ifølge Bloomberg News.

                                  I forhold til samme kvartal sidste år er Darzalex-salget steget 24 pct. i lokal valuta.

                                  For hele 2025 endte Johnson & Johnsons salg af Darzalex, som Genmab får procenter af, på 14.351 mio. dollar.

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Peter_Panik
                                    wrote on sidst redigeret af
                                    #237

                                    Det viser onsdagens regnskab fra Johnson & Johnson.

                                    Darzalex-salget lander dermed over Genmabs prognose for 2025 om et salg på 13,7 til 14,1 mia. dollar.

                                    Genmab estimerede i sit seneste regnskab, at det vil modtage royalties fra salget af Darzalex på 2,3-2,4 mia. dollar i 2025.

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Peter_Panik
                                      wrote on sidst redigeret af
                                      #238

                                      Isoleret set et stærkt resultat

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #239

                                        RYBREVANT / LAZCLUZE Q4 2025 US 146 Intl 70 WW 216 (Q3 2025 US 136 Intl 61 WW 198) (total 2025 734 vs 327 2024)

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #240

                                          TALVEY Q4 2025 149 (Q3 122), totals 463 (287) /// TECVAYLI 176 (Q3 177) totals 670 (549)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper